CA2685028A1 - Dispositif non chirurgical et procedes de stimulation du nerf vague trans-oesophagien - Google Patents
Dispositif non chirurgical et procedes de stimulation du nerf vague trans-oesophagien Download PDFInfo
- Publication number
- CA2685028A1 CA2685028A1 CA002685028A CA2685028A CA2685028A1 CA 2685028 A1 CA2685028 A1 CA 2685028A1 CA 002685028 A CA002685028 A CA 002685028A CA 2685028 A CA2685028 A CA 2685028A CA 2685028 A1 CA2685028 A1 CA 2685028A1
- Authority
- CA
- Canada
- Prior art keywords
- support member
- esophagus
- medical device
- vagus nerve
- implantable medical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 210000001186 vagus nerve Anatomy 0.000 title claims abstract description 97
- 230000007383 nerve stimulation Effects 0.000 title claims description 16
- 238000000034 method Methods 0.000 title abstract description 20
- 210000003238 esophagus Anatomy 0.000 claims abstract description 110
- 230000001225 therapeutic effect Effects 0.000 claims description 31
- 229920000642 polymer Polymers 0.000 claims description 10
- -1 polyethylene Polymers 0.000 claims description 7
- 229910052751 metal Inorganic materials 0.000 claims description 6
- 239000002184 metal Substances 0.000 claims description 6
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims description 4
- 239000004810 polytetrafluoroethylene Substances 0.000 claims description 4
- 230000036961 partial effect Effects 0.000 claims description 3
- 229920005573 silicon-containing polymer Polymers 0.000 claims description 3
- 239000004698 Polyethylene Substances 0.000 claims description 2
- 239000004743 Polypropylene Substances 0.000 claims description 2
- 239000000017 hydrogel Substances 0.000 claims description 2
- 229920001610 polycaprolactone Polymers 0.000 claims description 2
- 239000004632 polycaprolactone Substances 0.000 claims description 2
- 229920000573 polyethylene Polymers 0.000 claims description 2
- 229920001155 polypropylene Polymers 0.000 claims description 2
- 229920002635 polyurethane Polymers 0.000 claims description 2
- 239000004814 polyurethane Substances 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 238000002560 therapeutic procedure Methods 0.000 abstract description 30
- 230000000638 stimulation Effects 0.000 description 28
- 210000005036 nerve Anatomy 0.000 description 24
- 238000004891 communication Methods 0.000 description 15
- 230000000694 effects Effects 0.000 description 15
- 210000002784 stomach Anatomy 0.000 description 15
- 230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 description 11
- 230000003187 abdominal effect Effects 0.000 description 10
- 238000001514 detection method Methods 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 208000035475 disorder Diseases 0.000 description 8
- 238000002513 implantation Methods 0.000 description 8
- 230000001537 neural effect Effects 0.000 description 8
- 230000036982 action potential Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 210000005022 abdominal esophagus Anatomy 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 206010015037 epilepsy Diseases 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000000717 retained effect Effects 0.000 description 4
- 208000030814 Eating disease Diseases 0.000 description 3
- 208000019454 Feeding and Eating disease Diseases 0.000 description 3
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 3
- 208000008589 Obesity Diseases 0.000 description 3
- 239000000560 biocompatible material Substances 0.000 description 3
- 239000003990 capacitor Substances 0.000 description 3
- 210000003792 cranial nerve Anatomy 0.000 description 3
- 235000014632 disordered eating Nutrition 0.000 description 3
- 210000003236 esophagogastric junction Anatomy 0.000 description 3
- 230000002964 excitative effect Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 229910052744 lithium Inorganic materials 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 206010006550 Bulimia nervosa Diseases 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 208000017701 Endocrine disease Diseases 0.000 description 2
- 208000016621 Hearing disease Diseases 0.000 description 2
- HBBGRARXTFLTSG-UHFFFAOYSA-N Lithium ion Chemical compound [Li+] HBBGRARXTFLTSG-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- 208000027520 Somatoform disease Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 229920000249 biocompatible polymer Polymers 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- OJIJEKBXJYRIBZ-UHFFFAOYSA-N cadmium nickel Chemical compound [Ni].[Cd] OJIJEKBXJYRIBZ-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 230000007661 gastrointestinal function Effects 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 239000007943 implant Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 238000002357 laparoscopic surgery Methods 0.000 description 2
- 229910001416 lithium ion Inorganic materials 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000004899 motility Effects 0.000 description 2
- 230000004007 neuromodulation Effects 0.000 description 2
- 239000002858 neurotransmitter agent Substances 0.000 description 2
- 229910001000 nickel titanium Inorganic materials 0.000 description 2
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 208000027753 pain disease Diseases 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 210000003105 phrenic nerve Anatomy 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 230000002889 sympathetic effect Effects 0.000 description 2
- 239000003106 tissue adhesive Substances 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 208000032841 Bulimia Diseases 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 241000033257 Epizoanthus vagus Species 0.000 description 1
- 230000005355 Hall effect Effects 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000016222 Pancreatic disease Diseases 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 208000010024 Post-Head Injury Coma Diseases 0.000 description 1
- 208000024799 Thyroid disease Diseases 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 208000030886 Traumatic Brain injury Diseases 0.000 description 1
- 206010064155 Traumatic coma Diseases 0.000 description 1
- 208000013154 Vocal cord disease Diseases 0.000 description 1
- 210000003815 abdominal wall Anatomy 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000133 brain stem Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 208000012696 congenital leptin deficiency Diseases 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 230000005672 electromagnetic field Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000030135 gastric motility Effects 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000002102 hyperpolarization Effects 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000030214 innervation Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229910052741 iridium Inorganic materials 0.000 description 1
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 208000001022 morbid obesity Diseases 0.000 description 1
- 230000008035 nerve activity Effects 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 230000004766 neurogenesis Effects 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- HWLDNSXPUQTBOD-UHFFFAOYSA-N platinum-iridium alloy Chemical class [Ir].[Pt] HWLDNSXPUQTBOD-UHFFFAOYSA-N 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000009131 signaling function Effects 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Substances ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 230000009529 traumatic brain injury Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 230000001515 vagal effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0517—Esophageal electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36114—Cardiac control, e.g. by vagal stimulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0551—Spinal or peripheral nerve electrodes
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Electrotherapy Devices (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/796,158 US7869884B2 (en) | 2007-04-26 | 2007-04-26 | Non-surgical device and methods for trans-esophageal vagus nerve stimulation |
| US11/796,058 | 2007-04-26 | ||
| US11/796,058 US7904175B2 (en) | 2007-04-26 | 2007-04-26 | Trans-esophageal vagus nerve stimulation |
| US11/796,158 | 2007-04-26 | ||
| PCT/US2008/004469 WO2008133797A1 (fr) | 2007-04-26 | 2008-04-07 | Dispositif non chirurgical et procédés de stimulation du nerf vague trans-œsophagien |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2685028A1 true CA2685028A1 (fr) | 2008-11-06 |
Family
ID=41354053
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002685028A Abandoned CA2685028A1 (fr) | 2007-04-26 | 2008-04-07 | Dispositif non chirurgical et procedes de stimulation du nerf vague trans-oesophagien |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP2136873A1 (fr) |
| CA (1) | CA2685028A1 (fr) |
| WO (1) | WO2008133797A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9089707B2 (en) | 2008-07-02 | 2015-07-28 | The Board Of Regents, The University Of Texas System | Systems, methods and devices for paired plasticity |
| US8457757B2 (en) | 2007-11-26 | 2013-06-04 | Micro Transponder, Inc. | Implantable transponder systems and methods |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003503119A (ja) * | 1999-06-25 | 2003-01-28 | エモリ ユニバーシティ | 迷走神経刺激用機器及び方法 |
| US7844338B2 (en) * | 2003-02-03 | 2010-11-30 | Enteromedics Inc. | High frequency obesity treatment |
| US20050209653A1 (en) * | 2004-03-16 | 2005-09-22 | Medtronic, Inc. | Intra-luminal device for gastrointestinal electrical stimulation |
-
2008
- 2008-04-07 CA CA002685028A patent/CA2685028A1/fr not_active Abandoned
- 2008-04-07 WO PCT/US2008/004469 patent/WO2008133797A1/fr not_active Ceased
- 2008-04-07 EP EP08727307A patent/EP2136873A1/fr not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP2136873A1 (fr) | 2009-12-30 |
| WO2008133797A1 (fr) | 2008-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7904175B2 (en) | Trans-esophageal vagus nerve stimulation | |
| US7869884B2 (en) | Non-surgical device and methods for trans-esophageal vagus nerve stimulation | |
| US7962214B2 (en) | Non-surgical device and methods for trans-esophageal vagus nerve stimulation | |
| US20240157126A1 (en) | Modular Stimulation System for the Treatment of Gastrointestinal Disorders | |
| US8560076B2 (en) | Devices and methods for electrode implantation | |
| US7502650B2 (en) | Baroreceptor activation for epilepsy control | |
| US9827425B2 (en) | Methods and systems of electrode polarity switching in electrical stimulation therapy | |
| US20060173493A1 (en) | Multi-phasic signal for stimulation by an implantable device | |
| US20080195188A1 (en) | Implantable medical device with fixation mechanism | |
| US11839407B2 (en) | Treatment of obstructive sleep apnea (OSA) | |
| US12465761B2 (en) | Electrical stimulation system for the treatment of gastrointestinal disorders | |
| CA2685028A1 (fr) | Dispositif non chirurgical et procedes de stimulation du nerf vague trans-oesophagien | |
| JP2012120665A (ja) | 電気刺激装置および電極リード | |
| EP4608241A1 (fr) | Élément de fixation d'implant pour l'apnée obstructive du sommeil | |
| WO2024025686A1 (fr) | Aiguille pour implantation de fil pour apnée du sommeil obstructive |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Dead |